Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Summary

The purpose of this study is to allow subjects completing study LYC-30937-2001 the opportunity to receive LYC-30937-EC 25 mg.

Timeline

Start

2016-11-01

Primary completion

2018-07-18

Completion

2018-07-18

Outcome

Outcome not reported

Stopped: “Lack of efficacy of test drug”

Drugs

Indications